Go back

UK cancer R&D needs Vaccine Taskforce-like approach

Upcoming Cancer Research UK report set to detail “significant potential” for such taskforce

The widely praised UK government Vaccine Taskforce should be replicated for cancer, the director of policy at a leading research charity has said.

Hailed as a big success for the speed at which it achieved its aims, the taskforce was set up during the Covid-19 pandemic to coordinate government, industry, academia and funding agencies on research efforts to develop and deploy vaccines.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.